MindBio Expands AI Voice Tech to Detect Fatigue in High-Risk Workplaces

MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF), a biotechnology company at the forefront of AI-driven voice analysis, is expanding its technology to include fatigue detection for high-risk workplaces. The company, featured in a recent article, is developing a fatigue prediction model that will complement its existing alcohol and drug intoxication detection capabilities. This new feature is expected to be integrated into MindBio's planned Edge AI Intoxication Detection Kiosks, which use short voice samples to identify signs of impairment. The goal is to provide a non-invasive, scalable alternative to traditional methods like breathalyzers and saliva tests.

The core of MindBio's technology lies in its AI models, trained on over 50 million data points, to predict alcohol intoxication with remarkable accuracy using only the human voice. The company's enterprise platform includes Edge-AI kiosks with bespoke hardware and software, targeting industries such as mining, aviation, construction, and law enforcement. By analyzing speech characteristics captured through a microphone, the platform processes audio using machine learning models, offering a sample-free approach to impairment detection. This innovation positions MindBio as a leader in voice analytics for safety applications.

TechMediaWire, a specialized communications platform within the Dynamic Brand Portfolio of IBN, disseminated this news. TechMediaWire focuses on pioneering technology companies and provides services including press release distribution, editorial syndication to 5,000+ outlets, and social media distribution. The company helps public and private companies gain recognition and brand awareness in a crowded market. For more information on MindBio, visit their newsroom at https://ibn.fm/MBQIF.